Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Metabotropic Glutamate Receptor 7 Market Growth 2022-2028

  • LP 4928349
  • 73 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Metabotropic Glutamate Receptor 7 will have significant change from previous year. According to our (LP Information) latest study, the global Metabotropic Glutamate Receptor 7 market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Metabotropic Glutamate Receptor 7 market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Metabotropic Glutamate Receptor 7 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Metabotropic Glutamate Receptor 7 market, reaching US$ million by the year 2028. As for the Europe Metabotropic Glutamate Receptor 7 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Metabotropic Glutamate Receptor 7 players cover Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bio-Pharm Solutions Co Ltd, and Pragma Therapeutics SAS, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Metabotropic Glutamate Receptor 7 market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

JBPOS-0101

PGT-117

ADX-71743

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Generalized Anxiety Disorder

Infantile Spasm

Status Epilepticus

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Addex Therapeutics Ltd

Aevi Genomic Medicine Inc

Bio-Pharm Solutions Co Ltd

Pragma Therapeutics SAS

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Metabotropic Glutamate Receptor 7 Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Metabotropic Glutamate Receptor 7 by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Metabotropic Glutamate Receptor 7 by Country/Region, 2017, 2022 & 2028

2.2 Metabotropic Glutamate Receptor 7 Segment by Type

2.2.1 JBPOS-0101

2.2.2 PGT-117

2.2.3 ADX-71743

2.2.4 Others

2.3 Metabotropic Glutamate Receptor 7 Sales by Type

2.3.1 Global Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2017-2022)

2.3.2 Global Metabotropic Glutamate Receptor 7 Revenue and Market Share by Type (2017-2022)

2.3.3 Global Metabotropic Glutamate Receptor 7 Sale Price by Type (2017-2022)

2.4 Metabotropic Glutamate Receptor 7 Segment by Application

2.4.1 Generalized Anxiety Disorder

2.4.2 Infantile Spasm

2.4.3 Status Epilepticus

2.4.4 Others

2.5 Metabotropic Glutamate Receptor 7 Sales by Application

2.5.1 Global Metabotropic Glutamate Receptor 7 Sale Market Share by Application (2017-2022)

2.5.2 Global Metabotropic Glutamate Receptor 7 Revenue and Market Share by Application (2017-2022)

2.5.3 Global Metabotropic Glutamate Receptor 7 Sale Price by Application (2017-2022)

3 Global Metabotropic Glutamate Receptor 7 by Company

3.1 Global Metabotropic Glutamate Receptor 7 Breakdown Data by Company

3.1.1 Global Metabotropic Glutamate Receptor 7 Annual Sales by Company (2020-2022)

3.1.2 Global Metabotropic Glutamate Receptor 7 Sales Market Share by Company (2020-2022)

3.2 Global Metabotropic Glutamate Receptor 7 Annual Revenue by Company (2020-2022)

3.2.1 Global Metabotropic Glutamate Receptor 7 Revenue by Company (2020-2022)

3.2.2 Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Company (2020-2022)

3.3 Global Metabotropic Glutamate Receptor 7 Sale Price by Company

3.4 Key Manufacturers Metabotropic Glutamate Receptor 7 Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Metabotropic Glutamate Receptor 7 Product Location Distribution

3.4.2 Players Metabotropic Glutamate Receptor 7 Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Metabotropic Glutamate Receptor 7 by Geographic Region

4.1 World Historic Metabotropic Glutamate Receptor 7 Market Size by Geographic Region (2017-2022)

4.1.1 Global Metabotropic Glutamate Receptor 7 Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Metabotropic Glutamate Receptor 7 Annual Revenue by Geographic Region

4.2 World Historic Metabotropic Glutamate Receptor 7 Market Size by Country/Region (2017-2022)

4.2.1 Global Metabotropic Glutamate Receptor 7 Annual Sales by Country/Region (2017-2022)

4.2.2 Global Metabotropic Glutamate Receptor 7 Annual Revenue by Country/Region

4.3 Americas Metabotropic Glutamate Receptor 7 Sales Growth

4.4 APAC Metabotropic Glutamate Receptor 7 Sales Growth

4.5 Europe Metabotropic Glutamate Receptor 7 Sales Growth

4.6 Middle East & Africa Metabotropic Glutamate Receptor 7 Sales Growth

5 Americas

5.1 Americas Metabotropic Glutamate Receptor 7 Sales by Country

5.1.1 Americas Metabotropic Glutamate Receptor 7 Sales by Country (2017-2022)

5.1.2 Americas Metabotropic Glutamate Receptor 7 Revenue by Country (2017-2022)

5.2 Americas Metabotropic Glutamate Receptor 7 Sales by Type

5.3 Americas Metabotropic Glutamate Receptor 7 Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Metabotropic Glutamate Receptor 7 Sales by Region

6.1.1 APAC Metabotropic Glutamate Receptor 7 Sales by Region (2017-2022)

6.1.2 APAC Metabotropic Glutamate Receptor 7 Revenue by Region (2017-2022)

6.2 APAC Metabotropic Glutamate Receptor 7 Sales by Type

6.3 APAC Metabotropic Glutamate Receptor 7 Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Metabotropic Glutamate Receptor 7 by Country

7.1.1 Europe Metabotropic Glutamate Receptor 7 Sales by Country (2017-2022)

7.1.2 Europe Metabotropic Glutamate Receptor 7 Revenue by Country (2017-2022)

7.2 Europe Metabotropic Glutamate Receptor 7 Sales by Type

7.3 Europe Metabotropic Glutamate Receptor 7 Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Metabotropic Glutamate Receptor 7 by Country

8.1.1 Middle East & Africa Metabotropic Glutamate Receptor 7 Sales by Country (2017-2022)

8.1.2 Middle East & Africa Metabotropic Glutamate Receptor 7 Revenue by Country (2017-2022)

8.2 Middle East & Africa Metabotropic Glutamate Receptor 7 Sales by Type

8.3 Middle East & Africa Metabotropic Glutamate Receptor 7 Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor 7

10.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor 7

10.4 Industry Chain Structure of Metabotropic Glutamate Receptor 7

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Metabotropic Glutamate Receptor 7 Distributors

11.3 Metabotropic Glutamate Receptor 7 Customer

12 World Forecast Review for Metabotropic Glutamate Receptor 7 by Geographic Region

12.1 Global Metabotropic Glutamate Receptor 7 Market Size Forecast by Region

12.1.1 Global Metabotropic Glutamate Receptor 7 Forecast by Region (2023-2028)

12.1.2 Global Metabotropic Glutamate Receptor 7 Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Metabotropic Glutamate Receptor 7 Forecast by Type

12.7 Global Metabotropic Glutamate Receptor 7 Forecast by Application

13 Key Players Analysis

13.1 Addex Therapeutics Ltd

13.1.1 Addex Therapeutics Ltd Company Information

13.1.2 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Product Offered

13.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Addex Therapeutics Ltd Main Business Overview

13.1.5 Addex Therapeutics Ltd Latest Developments

13.2 Aevi Genomic Medicine Inc

13.2.1 Aevi Genomic Medicine Inc Company Information

13.2.2 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Product Offered

13.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Aevi Genomic Medicine Inc Main Business Overview

13.2.5 Aevi Genomic Medicine Inc Latest Developments

13.3 Bio-Pharm Solutions Co Ltd

13.3.1 Bio-Pharm Solutions Co Ltd Company Information

13.3.2 Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Product Offered

13.3.3 Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bio-Pharm Solutions Co Ltd Main Business Overview

13.3.5 Bio-Pharm Solutions Co Ltd Latest Developments

13.4 Pragma Therapeutics SAS

13.4.1 Pragma Therapeutics SAS Company Information

13.4.2 Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Product Offered

13.4.3 Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pragma Therapeutics SAS Main Business Overview

13.4.5 Pragma Therapeutics SAS Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Metabotropic Glutamate Receptor 7 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Metabotropic Glutamate Receptor 7 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of JBPOS-0101

Table 4. Major Players of PGT-117

Table 5. Major Players of ADX-71743

Table 6. Major Players of Others

Table 7. Global Metabotropic Glutamate Receptor 7 Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2017-2022)

Table 9. Global Metabotropic Glutamate Receptor 7 Revenue by Type (2017-2022) & ($ million)

Table 10. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Type (2017-2022)

Table 11. Global Metabotropic Glutamate Receptor 7 Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Metabotropic Glutamate Receptor 7 Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2017-2022)

Table 14. Global Metabotropic Glutamate Receptor 7 Revenue by Application (2017-2022)

Table 15. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Application (2017-2022)

Table 16. Global Metabotropic Glutamate Receptor 7 Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Metabotropic Glutamate Receptor 7 Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Company (2020-2022)

Table 19. Global Metabotropic Glutamate Receptor 7 Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Company (2020-2022)

Table 21. Global Metabotropic Glutamate Receptor 7 Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Metabotropic Glutamate Receptor 7 Producing Area Distribution and Sales Area

Table 23. Players Metabotropic Glutamate Receptor 7 Products Offered

Table 24. Metabotropic Glutamate Receptor 7 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Metabotropic Glutamate Receptor 7 Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Metabotropic Glutamate Receptor 7 Sales Market Share Geographic Region (2017-2022)

Table 29. Global Metabotropic Glutamate Receptor 7 Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Metabotropic Glutamate Receptor 7 Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Country/Region (2017-2022)

Table 33. Global Metabotropic Glutamate Receptor 7 Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Metabotropic Glutamate Receptor 7 Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Metabotropic Glutamate Receptor 7 Sales Market Share by Country (2017-2022)

Table 37. Americas Metabotropic Glutamate Receptor 7 Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Metabotropic Glutamate Receptor 7 Revenue Market Share by Country (2017-2022)

Table 39. Americas Metabotropic Glutamate Receptor 7 Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2017-2022)

Table 41. Americas Metabotropic Glutamate Receptor 7 Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2017-2022)

Table 43. APAC Metabotropic Glutamate Receptor 7 Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Metabotropic Glutamate Receptor 7 Sales Market Share by Region (2017-2022)

Table 45. APAC Metabotropic Glutamate Receptor 7 Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Metabotropic Glutamate Receptor 7 Revenue Market Share by Region (2017-2022)

Table 47. APAC Metabotropic Glutamate Receptor 7 Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2017-2022)

Table 49. APAC Metabotropic Glutamate Receptor 7 Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2017-2022)

Table 51. Europe Metabotropic Glutamate Receptor 7 Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Metabotropic Glutamate Receptor 7 Sales Market Share by Country (2017-2022)

Table 53. Europe Metabotropic Glutamate Receptor 7 Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Metabotropic Glutamate Receptor 7 Revenue Market Share by Country (2017-2022)

Table 55. Europe Metabotropic Glutamate Receptor 7 Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2017-2022)

Table 57. Europe Metabotropic Glutamate Receptor 7 Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Metabotropic Glutamate Receptor 7 Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Metabotropic Glutamate Receptor 7 Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Metabotropic Glutamate Receptor 7 Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Metabotropic Glutamate Receptor 7 Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Metabotropic Glutamate Receptor 7 Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Metabotropic Glutamate Receptor 7 Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Metabotropic Glutamate Receptor 7 Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Metabotropic Glutamate Receptor 7

Table 68. Key Market Challenges & Risks of Metabotropic Glutamate Receptor 7

Table 69. Key Industry Trends of Metabotropic Glutamate Receptor 7

Table 70. Metabotropic Glutamate Receptor 7 Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Metabotropic Glutamate Receptor 7 Distributors List

Table 73. Metabotropic Glutamate Receptor 7 Customer List

Table 74. Global Metabotropic Glutamate Receptor 7 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Metabotropic Glutamate Receptor 7 Sales Market Forecast by Region

Table 76. Global Metabotropic Glutamate Receptor 7 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Metabotropic Glutamate Receptor 7 Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Metabotropic Glutamate Receptor 7 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Metabotropic Glutamate Receptor 7 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Metabotropic Glutamate Receptor 7 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Metabotropic Glutamate Receptor 7 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Metabotropic Glutamate Receptor 7 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Metabotropic Glutamate Receptor 7 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Metabotropic Glutamate Receptor 7 Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Metabotropic Glutamate Receptor 7 Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Metabotropic Glutamate Receptor 7 Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Metabotropic Glutamate Receptor 7 Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Metabotropic Glutamate Receptor 7 Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Metabotropic Glutamate Receptor 7 Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Metabotropic Glutamate Receptor 7 Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Metabotropic Glutamate Receptor 7 Revenue Market Share Forecast by Application (2023-2028)

Table 94. Addex Therapeutics Ltd Basic Information, Metabotropic Glutamate Receptor 7 Manufacturing Base, Sales Area and Its Competitors

Table 95. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Product Offered

Table 96. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. Addex Therapeutics Ltd Main Business

Table 98. Addex Therapeutics Ltd Latest Developments

Table 99. Aevi Genomic Medicine Inc Basic Information, Metabotropic Glutamate Receptor 7 Manufacturing Base, Sales Area and Its Competitors

Table 100. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Product Offered

Table 101. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. Aevi Genomic Medicine Inc Main Business

Table 103. Aevi Genomic Medicine Inc Latest Developments

Table 104. Bio-Pharm Solutions Co Ltd Basic Information, Metabotropic Glutamate Receptor 7 Manufacturing Base, Sales Area and Its Competitors

Table 105. Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Product Offered

Table 106. Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. Bio-Pharm Solutions Co Ltd Main Business

Table 108. Bio-Pharm Solutions Co Ltd Latest Developments

Table 109. Pragma Therapeutics SAS Basic Information, Metabotropic Glutamate Receptor 7 Manufacturing Base, Sales Area and Its Competitors

Table 110. Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Product Offered

Table 111. Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. Pragma Therapeutics SAS Main Business

Table 113. Pragma Therapeutics SAS Latest Developments

List of Figures

Figure 1. Picture of Metabotropic Glutamate Receptor 7

Figure 2. Metabotropic Glutamate Receptor 7 Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Metabotropic Glutamate Receptor 7 Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Metabotropic Glutamate Receptor 7 Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Metabotropic Glutamate Receptor 7 Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of JBPOS-0101

Figure 10. Product Picture of PGT-117

Figure 11. Product Picture of ADX-71743

Figure 12. Product Picture of Others

Figure 13. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Type in 2021

Figure 14. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Type (2017-2022)

Figure 15. Metabotropic Glutamate Receptor 7 Consumed in Generalized Anxiety Disorder

Figure 16. Global Metabotropic Glutamate Receptor 7 Market: Generalized Anxiety Disorder (2017-2022) & (K Pcs)

Figure 17. Metabotropic Glutamate Receptor 7 Consumed in Infantile Spasm

Figure 18. Global Metabotropic Glutamate Receptor 7 Market: Infantile Spasm (2017-2022) & (K Pcs)

Figure 19. Metabotropic Glutamate Receptor 7 Consumed in Status Epilepticus

Figure 20. Global Metabotropic Glutamate Receptor 7 Market: Status Epilepticus (2017-2022) & (K Pcs)

Figure 21. Metabotropic Glutamate Receptor 7 Consumed in Others

Figure 22. Global Metabotropic Glutamate Receptor 7 Market: Others (2017-2022) & (K Pcs)

Figure 23. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2017-2022)

Figure 24. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Application in 2021

Figure 25. Metabotropic Glutamate Receptor 7 Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Company in 2021

Figure 27. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Geographic Region in 2021

Figure 29. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Region (2017-2022)

Figure 30. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Country/Region in 2021

Figure 31. Americas Metabotropic Glutamate Receptor 7 Sales 2017-2022 (K Pcs)

Figure 32. Americas Metabotropic Glutamate Receptor 7 Revenue 2017-2022 ($ Millions)

Figure 33. APAC Metabotropic Glutamate Receptor 7 Sales 2017-2022 (K Pcs)

Figure 34. APAC Metabotropic Glutamate Receptor 7 Revenue 2017-2022 ($ Millions)

Figure 35. Europe Metabotropic Glutamate Receptor 7 Sales 2017-2022 (K Pcs)

Figure 36. Europe Metabotropic Glutamate Receptor 7 Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Metabotropic Glutamate Receptor 7 Sales 2017-2022 (K Pcs)

Figure 38. Middle East & Africa Metabotropic Glutamate Receptor 7 Revenue 2017-2022 ($ Millions)

Figure 39. Americas Metabotropic Glutamate Receptor 7 Sales Market Share by Country in 2021

Figure 40. Americas Metabotropic Glutamate Receptor 7 Revenue Market Share by Country in 2021

Figure 41. United States Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Metabotropic Glutamate Receptor 7 Sales Market Share by Region in 2021

Figure 46. APAC Metabotropic Glutamate Receptor 7 Revenue Market Share by Regions in 2021

Figure 47. China Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Metabotropic Glutamate Receptor 7 Sales Market Share by Country in 2021

Figure 54. Europe Metabotropic Glutamate Receptor 7 Revenue Market Share by Country in 2021

Figure 55. Germany Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Metabotropic Glutamate Receptor 7 Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Metabotropic Glutamate Receptor 7 Revenue Market Share by Country in 2021

Figure 62. Egypt Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Metabotropic Glutamate Receptor 7 Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor 7 in 2021

Figure 68. Manufacturing Process Analysis of Metabotropic Glutamate Receptor 7

Figure 69. Industry Chain Structure of Metabotropic Glutamate Receptor 7

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390